tiprankstipranks
Advertisement
Advertisement

KRYS Stock Latest News

Krystal Biotech Updates KB801 Patent Office Filing
Company AnnouncementsKrystal Biotech Updates KB801 Patent Office Filing
17s ago
8K
KRYS
Krystal Biotech to replace Taylor Morrison in S&P 400 at open on 7/24
PremiumThe Fly
Krystal Biotech to replace Taylor Morrison in S&P 400 at open on 7/24
1d ago
KRYS
TMHC
Tutor Perini to replace Krystal Biotech in S&P 600 at open on 7/24
PremiumThe Fly
Tutor Perini to replace Krystal Biotech in S&P 600 at open on 7/24
1d ago
TPC
KRYS
Krystal Biotech price target raised to $396 from $364 at BofA
PremiumThe Fly
Krystal Biotech price target raised to $396 from $364 at BofA
7d ago
KRYS
Krystal Biotech price target raised to $474 from $399 at Jefferies
PremiumThe Fly
Krystal Biotech price target raised to $474 from $399 at Jefferies
8d ago
KRYS
Krystal Biotech price target raised to $403 from $306 at TD Cowen
PremiumThe FlyKrystal Biotech price target raised to $403 from $306 at TD Cowen
1M ago
KRYS
Krystal Biotech price target raised to $361 from $310 at H.C. Wainwright
Premium
The Fly
Krystal Biotech price target raised to $361 from $310 at H.C. Wainwright
1M ago
KRYS
Krystal Biotech Shareholders Approve Directors and Compensation
Premium
Company Announcements
Krystal Biotech Shareholders Approve Directors and Compensation
2M ago
8K
KRYS
Analyst Reiterates Buy on Krystal Biotech as Vyjuvek Global Launch and Growing Rare-Disease Pipeline Underpin Long-Term Upside
PremiumRatings
Analyst Reiterates Buy on Krystal Biotech as Vyjuvek Global Launch and Growing Rare-Disease Pipeline Underpin Long-Term Upside
2M ago
KRYS
Krystal Biotech announces UK MHRA approval of Vyjuvek
PremiumThe Fly
Krystal Biotech announces UK MHRA approval of Vyjuvek
2M ago
KRYS
U.K.’s MHRA approves Krystal’s Vyjuvek for dystrophic epidermolysis bullosa
PremiumThe Fly
U.K.’s MHRA approves Krystal’s Vyjuvek for dystrophic epidermolysis bullosa
2M ago
KRYS
Krystal Biotech price target raised to $300 from $295 at Evercore ISI
PremiumThe Fly
Krystal Biotech price target raised to $300 from $295 at Evercore ISI
3M ago
KRYS
Krystal Biotech price target raised to $378 from $371 at Citi
PremiumThe FlyKrystal Biotech price target raised to $378 from $371 at Citi
3M ago
KRYS
Krystal Biotech Earnings Call Highlights Profitable Growth
Premium
Company Announcements
Krystal Biotech Earnings Call Highlights Profitable Growth
3M ago
KRYS
Krystal Biotech price target lowered to $311 from $338 at Clear Street
Premium
The Fly
Krystal Biotech price target lowered to $311 from $338 at Clear Street
3M ago
KRYS
Krystal Biotech sees FY26 R&D and SG&A expense $175M-$195M
PremiumThe Fly
Krystal Biotech sees FY26 R&D and SG&A expense $175M-$195M
3M ago
KRYS
Krystal Biotech reports Q1 EPS $1.83, consensus $1.42
PremiumThe Fly
Krystal Biotech reports Q1 EPS $1.83, consensus $1.42
3M ago
KRYS
KRYS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
KRYS Earnings this Week: How Will it Perform?
3M ago
KRYS
Krystal Biotech: Valuation Reflects Pipeline Optimism Amid Dosing and Efficacy Risks, Justifying a Hold Rating
PremiumRatings
Krystal Biotech: Valuation Reflects Pipeline Optimism Amid Dosing and Efficacy Risks, Justifying a Hold Rating
4M ago
KRYS
Krystal Biotech initiated with a Peer Perform at Wolfe Research
PremiumThe FlyKrystal Biotech initiated with a Peer Perform at Wolfe Research
4M ago
KRYS
Krystal Biotech price target raised to $325 from $318 at BofA
Premium
The Fly
Krystal Biotech price target raised to $325 from $318 at BofA
4M ago
KRYS
Krystal Biotech price target raised to $284 from $224 at Guggenheim
Premium
The Fly
Krystal Biotech price target raised to $284 from $224 at Guggenheim
5M ago
KRYS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >